Shandong Jincheng Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Shandong Jincheng Pharmaceutical Group has a total shareholder equity of CN¥3.8B and total debt of CN¥592.4M, which brings its debt-to-equity ratio to 15.7%. Its total assets and total liabilities are CN¥5.6B and CN¥1.8B respectively. Shandong Jincheng Pharmaceutical Group's EBIT is CN¥221.2M making its interest coverage ratio 54.1. It has cash and short-term investments of CN¥941.3M.
Key information
15.7%
Debt to equity ratio
CN¥592.43m
Debt
| Interest coverage ratio | 54.1x |
| Cash | CN¥941.29m |
| Equity | CN¥3.76b |
| Total liabilities | CN¥1.84b |
| Total assets | CN¥5.60b |
Recent financial health updates
Recent updates
Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Bounce 39% But Its Business Still Trails The Market
Oct 08
Estimating The Intrinsic Value Of Shandong Jincheng Pharmaceutical Group Co., Ltd (SZSE:300233)
Oct 07Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Popularity With Investors Is Under Threat From Overpricing
Jun 07Shandong Jincheng Pharmaceutical Group's (SZSE:300233) Problems Go Beyond Weak Profit
Apr 04Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Climb 29% But Its Business Is Yet to Catch Up
Mar 04Shandong Jincheng Pharmaceutical Group (SZSE:300233) Seems To Use Debt Quite Sensibly
Mar 02Financial Position Analysis
Short Term Liabilities: 300233's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.3B).
Long Term Liabilities: 300233's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥501.9M).
Debt to Equity History and Analysis
Debt Level: 300233 has more cash than its total debt.
Reducing Debt: 300233's debt to equity ratio has increased from 11.6% to 15.7% over the past 5 years.
Debt Coverage: 300233's debt is well covered by operating cash flow (68.3%).
Interest Coverage: 300233's interest payments on its debt are well covered by EBIT (54.1x coverage).